Establishment Labs

United States
Troy, New Hampshire, United States, 10019-4108

Company profile

Establishment Labs company profile

Establishment Labs is a medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to the strictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®’s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction. All manufacturing facilities are fully compliant with both FDA and ISO applicable standards.

Business identity

Contact email
[email protected]
Phone number
506-2434-2400
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$10M-$100M
Founded
2004-01-01, Year

Headquarters

Postal code
10019-4108
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
9
Total equity funding
$340.7M
Last funding
Post IPO Equity / $50M / 2024-11-07
Last equity funding
Post IPO Equity / $50M
Investors
10
Lead investors
9
Founders
1
Articles
159
Exited on
2018-07-18

Founders and investors

Founders

Juan José

Lead investors

Crown Predator HoldingsFlorence Capital AdvisorsJW Asset ManagementKilowatt Capital LLCMadryn Asset ManagementNantahala Capital ManagementOaktree Capital ManagementPerceptive AdvisorsRTW Investments

Investors

Madryn Asset ManagementNantahala Capital ManagementOaktree Capital ManagementPerceptive AdvisorsRTW Investments